# Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage

Study · id `cardio:ct-nct02367248` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02367248](<https://clinicaltrials.gov/study/NCT02367248>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02367248

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT02367248. Randomized; quadruple masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT02367248, source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)
- Start date: 2015-03 (registry gives no type) (ClinicalTrials.gov record NCT02367248, source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02367248, source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)
- Completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02367248, source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02367248, source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02367248-2015-05-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): deferoxamine
- Intervention (Drug): Xingnaojing injection
- Intervention (Drug): Normal saline
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER
- Collaborator: Peking University First Hospital
- Collaborator class: OTHER
- Collaborator: People's Hospital of Beijing Daxing District
- Collaborator class: OTHER
- Collaborator: Beijing Haidian Hospital
- Collaborator class: OTHER
- Collaborator: The 263 Hospital of PLA
- Collaborator class: UNKNOWN
- Collaborator: Beijing Aerospace General Hospital
- Collaborator class: OTHER
- Collaborator: Peking University Third Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Pinggu District Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Shuyi Hospital
- Collaborator class: OTHER
- Collaborator: General Hospital of Beijing PLA Military Region
- Collaborator class: OTHER
- Collaborator: Beijing Luhe Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Fangshan District Liangxiang Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Neurosurgical Institute
- Collaborator class: OTHER
- Collaborator: Beijing Jishuitan Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Ditan Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Youyi Hospital
- Collaborator class: UNKNOWN
- Collaborator: Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Collaborator class: OTHER
- Collaborator: Peking University People's Hospital
- Collaborator class: OTHER
- Collaborator: The Second Artillery General Hospital
- Collaborator class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)
- Registry lists this organization as a collaborator: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)
- Registry lists this organization as a collaborator: Peking University First Hospital (`cardio:org-peking-university-first-hospital`)
- Registry lists this organization as a collaborator: People's Hospital of Beijing Daxing District (`cardio:org-people-s-hospital-of-beijing-daxing-district`)
- Registry lists this organization as a collaborator: Peking University Third Hospital (`cardio:org-peking-university-third-hospital`)
- Registry lists this organization as a collaborator: Xiyuan Hospital of China Academy of Chinese Medical Sciences (`cardio:org-xiyuan-hospital-of-china-academy-of-chinese-medical-sciences`)
- Registry lists this organization as a collaborator: Peking University People's Hospital (`cardio:org-peking-university-people-s-hospital`)
- Registry lists this organization as a collaborator: Chinese PLA General Hospital (`cardio:org-chinese-pla-general-hospital`)

## Provenance

Content hash: e8a4debb3979bdaf21deceab1f567084deeea6a2069ef35f63dc2dc70705a154
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
